All glioblastoma articles
-
NewsEngineered virus boosts immune response against glioblastoma in preclinical models
Researchers have modified a herpes simplex virus (HSV-1) that stimulates the immune system to attack glioblastoma cells. A single dose of the modified virus increased T-cell, natural killer cell, and myeloid cell responses in the tumor microenvironment and increased the overall survival in preclinical models.
-
NewsNew immunotherapy strategy targets difficult-to-treat brain tumors with gut microbiota
Researchers have demonstrated a new therapeutic strategy that can enhance the efficacy of immunotherapy for brain tumors by utilizing gut microbes and their metabolites. This also opens up possibilities for developing microbiome-based immunotherapy supplements in the future.
-
NewsCombining laboratory techniques yields wealth of information about deadly brain tumors
In a new study, researchers injected into the tumor a virus aimed at killing glioblastoma cells. Surgeons took tumor tissue samples and ran them through multiple advanced laboratory techniques to demonstrate that even small tissue samples can yield additional insights.
-
NewsVirus aids breakthrough in glioblastoma treatment
Scientists have reported a breakthrough in glioblastoma treatment following a recent clinical trial that used a modified cold virus injected directly into the tumor.
-
NewsEngineered virus with immunotherapy safe and improves cancer outcomes
A new study validates the safety of a combination approach using an engineered virus and immunotherapy to target an aggressive brain cancer, and offers promise to adapt treatment strategies.